The European Medicine’s Agency (EMA) human medicines committee (CHMP) has adopted several recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines in the EU....
The European Medicines Agency (EMA) safety committee has concluded that the AstraZeneca vaccine’s proven efficacy in preventing hospitalization and death from COVID-19 outweighs the extremely small...
On 17 February, the European Commission launched its “HERA Incubator” to address the threat of new coronavirus variants. HERA will work with researchers, biotech companies, manufacturers...
Over the last few weeks, EMA has made good progress on the assessment of the marketing authorisation application for Moderna’s mRNA-1273 COVID-19 vaccine. A continuous dialogue...
EMA’s human medicines committee (CHMP) and its experts have been working intensively over the past weeks to evaluate data submitted by BioNTech and Pfizer in the...
The European Commission launched new proposals today (11 November) aimed at building a stronger European Health Union with a focus on EU's health security. Stella Kyriakides,...
Rare disease patients in Europe got a boost in late December after a European Medicines Agency (EMA) experts’ panel recommended seven medicines for approval, including two...
